19
Results Presentation Investor Road Show May 2012 2012 FULL YEAR

2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

Results Presentation

Investor Road Show May 2012

2012 FULL YEAR

Page 2: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

• This presentation has been prepared by Campbell Brothers Limited, (CBL or the Company). It contains general

information about the Company’s activities as at the date of the presentation. It is information given in

summary form and does not purport to be complete. The distribution of this presentation in jurisdictions

outside Australia may be restricted by law, and you should observe any such restrictions.

• This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in

respect of securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy,

securities in any jurisdiction. Neither this document nor anything in it shall form the basis of any contract or

commitment. This presentation is not intended to be relied upon as advice to investors or potential investors

and does not take into account the investment objectives, financial situation or needs of any investor. All

investors should consider such factors in consultation with a professional advisor of their choosing when

deciding if an investment is appropriate.

• The Company has prepared this presentation based on information available to it, including information

derived from public sources that have not been independently verified. No representation or warranty, express

or implied, is provided in relation to the fairness, accuracy, correctness, completeness or reliability of the

information, opinions or conclusions expressed herein.

• This presentation includes forward-looking statements within the meaning of securities laws. Any forward-

looking statements involve known and unknown risks and uncertainties, many of which are outside the control

of the Company and its representatives. Forward-looking statements may also be based on estimates and

assumptions with respect to future business decisions, which are subject to change. Any statements,

assumptions, opinions or conclusions as to future matters may prove to be incorrect, and actual results,

performance or achievement may vary materially from any projections and forward-looking statements.

• Due care and attention should be undertaken when considering and analysing the financial performance of the

Company.

• All references to dollars are to Australian currency unless otherwise stated.

IMPORTANT NOTICE AND DISCLAIMER

2

Page 3: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

3

March 2012 Full Year Snapshot

pre unusual items

REVENUE

31st March 2012

$1406mn

EBITDA

31st March 2012

$374mn

NPAT

31st March 2012

$222mn

0 250 500 750 1000 1250 1500

FY12

FY11

FY10

FY09

FY08

FY08 FY09 FY10 FY11 FY12

Average USD:AUD (cents) 88 79 86 95 105

0 60 120 180 240 300 360

FY12

FY11

FY10

FY09

FY08

0 40 80 120 160 200 240

FY12

FY11

FY10

FY09

FY08

27

%

57

%

68

%

Page 4: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

4

Full Year Results – Overview

excluding unusual items

Mar 12 Mar 11 Change

Revenue ($mn) 1,406 1,108 +27%

EBITDA ($mn) 374 238 +57%

Profit before tax ($mn) 312 186 +68%

Net profit after tax ($mn) 222.4 132.2 +68%

Wtd. ave. number of shares 67,503,000 65,139,000 +4%

Earnings per share (c) 329 203 +62%

Full Year Dividend (c) 225 140 +61%

Number of employees

Includes full time, part time and casuals

12,101 8,936 +35%

Safety Statistic – LTIFR 3.0 2.5

Page 5: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

5

Maintenance of Dividend Policy

$0.00 $0.20 $0.40 $0.60 $0.80 $1.00 $1.20 $1.40 $1.60 $1.80 $2.00 $2.20 $2.40

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

Year En

d M

arch

Main

tain

ing D

ivid

end G

row

th

Total dividend $2.25 - 68% payout ratio

Page 6: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

-100% 0% 100% 200% 300% 400% 500% 600% 700%

Coffey

Servcorp

Transfield Services

SGS

Ausenco

Worley Parsons

Clough

Eurofins

Orica

MacMahon

Bureau Veritas

Intertek

Cardno

Monadelphous

Core Laboratories

Boart Longyear

Campbell Brothers

Total Shareholder Return (1st April 2009 to 31st March 2012)

Total Shareholder Return

– last three year period

Source- Ernst & Young

6

Page 7: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

7

ALS - New Divisional Structure

49%

31%

7%

13%

Revenue by Division

- Four Global Divisions

- Ten Business Streams

Page 8: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

8

ALS Group

Full Year Snapshot

REVENUE

31st March 2012

$1192mn

EBITDA

31st March 2012

$385mn

EBIT

31st March 2012

$341mn

0

50

100

150

200

250

300

350

400

0

200

400

600

800

1000

1200

FY08 FY09 FY10 FY11 FY12

EBIT

DA

&

EBIT

(A

UD

m

illio

n)

Reven

ue (A

UD

m

illio

n)

Revenue EBITDA EBIT

Average USD:AUD (cents)

88 79 86 95 105

39

%

54

%

61

%

Page 9: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

-

200

400

600

800

1,000

1,200

1,400

FY06 FY07 FY08 FY09 FY10 FY11 FY12

AU

D$

m

illio

ns

-

50

100

150

200

250

300

350

400

FY06 FY07 FY08 FY09 FY10 FY11 FY12

AU

D$

m

illio

ns

Non-Mineral EBITDA margin

21% 21% 24% 20% 24% 23% 25%

Growth of non-Minerals Divisions

Life Sciences Energy Industrial Minerals

Revenue EBITDA (incl ALS overheads)

The non-Minerals revenue of ALS is now larger than ALS’ entire revenue only two years ago and the

Minerals Division has been transformed from a geochemical only business in 2009 to a geochemical,

metallurgical and inspection business in 2012.

9

Page 10: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

0

200

400

600

800

1000

1200

1400

FY 2011 Organic Acquired FX FY 2012

ALS R

even

ue A

UD

$

millio

n

Constant Currency

Growth 46%

ALS Group Revenue Performance

Reported Growth 39%

46%

5%

32%

5%

5% 7%

44%

4%

32%

5%

6%

9%

Revenue by Geography

FY11 Vs FY12

Australia

Asia

Nth America

Sth America

Africa

Europe

39%

36%

8%

17%

49%

31%

7%

13%

Revenue by Division

FY11 Vs FY12

Minerals

Life Sciences

Energy

Industrial

10

Page 11: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

ALS Group Performance

0%

5%

10%

15%

20%

25%

30%

35%

40%

Minerals Life Sciences Energy Industrial

EBIT Margin (incl. ALS overheads)

FY2011

FY2012

-20% -10% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90%

Minerals

Life Sciences

Energy

Industrial

Revenue Growth

Organic Acquired FX Impact

11

Page 12: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

12

Overview

• Acquisition (AUD$222mn) and integration of Stewart

Group very successful

• 16 new or refurbished laboratories completed

• Successful introduction of CoreViewerTM

• Expansion in central Asia

• Significant capacity increase in Kamloops

metallurgical laboratory

• Pricing stabilised

Outlook

• Favourable market conditions through 2013

• 14 new or refurbished laboratories planned

• New 7000 m2

Santiago geochemistry and

metallurgical laboratory to be operational by January

2013

• High Pressure Acid Leach pilot plant to be installed

in Perth

• New hub laboratory in Ireland

• Iron Ore Technical Centre to be built in Perth

• Commissioning of new hub lab in Johannesburg by

July 2012

2012 2011 Change

Revenue $591mn $334mn 77%

EBITDA $234mn $127mn 84%

EBIT $215mn $112mn 92%

EBIT Margin 36.3% 33.4% +290bps

Minerals Division

Geochemistry

Metallurgy

Inspection

Other

r

e

v

e

n

u

e

Page 13: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

13

Overview

• Acquisition (AUD$40mn) and integration of

Columbia Analytical Services very successful

• Acquisition (AUD$40mn) of Eclipse and AMS

completed in April 2012

• Introduced mobile app for environmental clients

• Australian and Scandinavian markets strong

Outlook

• Focus on expanding food/pharma revenues

• New food/pharma laboratories in Melbourne, Sydney

& Brisbane

• Refurbish or new environmental laboratories in

Brisbane, Sydney, Calgary, Singapore, Hong Kong,

Kuala Lumpur, Jakarta

• Further development of air markets

• New generation LIMS to be rolled out to all

laboratories over next two years

2012 2011 Change

Revenue $361mn $308mn 17%

EBITDA $96mn $82mn 17%

EBIT $78mn $66mn 18%

EBIT Margin 21.7% 21.5% +20bps

Life Sciences Division

Australia

Asia

Nth America

Europe

* Includes a full year for CAS acquisition in North America

r

e

v

e

n

u

e

Page 14: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

14

Overview

• Excellent year, far exceeding industry growth rates

• Laboratory industry leading safety record; LTIFR =

2.4

• Full commissioning of the new Brisbane laboratory –

the largest coal analytical laboratory in the world

• New laboratories built in Emerald and Bowen

• New LIMS rolled out to all Australian laboratories

• Successful integration of the anglo American Central

Laboratory in South Africa and the Stewart Group

laboratory in Mongolia

Outlook

• New “Energy Division” created to focus attention on

oil and gas upstream opportunities

• Further capacity build out of Brisbane laboratory

• Expansion into Indonesia underway with

Mozambique, China and USA under consideration

• New site with larger capacity being developed in

Mongolia

2012 2011 Change

Revenue $88mn $73mn 20%

EBITDA $26.6mn $19.9mn 34%

EBIT $23.7mn $17.2mn 38%

EBIT Margin 26.9% 23.6% +330bps

Energy Division

Australia

Asia

Nth America

Africa

r

e

v

e

n

u

e

Page 15: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

15

Overview

• Strong year leverage off continuing improvement

from previous year

• Disposal of PearlStreet Energy Services allows focus

on Asset Care business

• Acquistion (AUD$40mn )of PowerServices very

successful

• Strong margin improvement

• Advanced Engineering Services model rolled out

• A number of major shutdown projects delayed into

2012-13

• Delays on some major infrastructure projects

previously won

Outlook

• Focus on expansion of business outside of Australia

• Introduction of further high-end technologies

• Continued market and market share growth

2012 2011 Change

Revenue $153mn $142mn 8%

EBITDA $29.0mn $20.6mn 41%

EBIT $24.5mn $16.6mn 48%

EBIT Margin 16.0% 11.7% +430bps

Industrial Division

Australia

Sth America

Nth America

Africa

r

e

v

e

n

u

e

Page 16: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

16

Overview

• Record sales and operating profit for the Panamex

Group

• Revenue down as a result of Cleantec disposal

• Strong sales in Papua New Guinea

• Better cost control across all business sites

• Deltrex sales in Australia subdued due to

contraction in manufacturing sector, customer

factory closures and adverse weather

• Some one off costs incurred in decoupling the

Cleantec business

Outlook

• Panamex expecting a strong year with further

growth in Papua New Guinea and the French

territories

• Deltrex expecting modest growth with opportunities

in the resources sector

2012 2011 Change

Revenue $90mn $130mn (31)%

EBITDA $8.8mn $9.8mn (10)%

EBIT $8.1mn $7.4mn 9%

EBIT Margin 9.0% 5.7% +330bps

Campbell Chemical Division

Page 17: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

17

Overview

• Significant turnaround from previous year

• Excluding discontinued New Zealand operations,

revenue up 3.8% in Australia on previous year

• Reduction in inventory

• Disposal of underperforming New Zealand

operations

• Strong import program

• Increase in productivity and lower head count

• Successful rollout of The Hospitality Stores

Outlook

• Further growth in revenue and margin in 2012-13

• Import program extended with broadening of owned

brands

• Improved market conditions in mining and

hospitality

2012 2011 Change

Revenue $123mn $124mn (0.6)%

EBITDA $4.5mn ($0.6)mn N.A.

EBIT $3.7mn ($1.8)mn N.A.

EBIT Margin 3.0% (1.5)% +450bps

Reward Distribution Division

Page 18: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

Organic Investment Paying Off

18

23%

28%

14%

18%

25%

FY2008 FY2009 FY2010 FY2011 FY2012

Return on Equity

50

72

43

71

83

FY2008 FY2009 FY2010 FY2011 FY2012

CAPEX (AUD$mn)

Page 19: 2012 FULL YEARMay 21, 2012  · FY 2011 Organic Acquired FX FY 2012 n 46% Constant Currency ... • Favourable market conditions through 2013 • 14 new or refurbished laboratories

19

Debt Maturity Profile

123

76

29

92

116

135

0

40

80

120

160

200

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022

AU

D $

millio

n

Year

Bank Bank Capacity USPP

Note: Gearing defined as Net Debt as a percentage of Net Debt plus Equity was 28% at the 31st March 2012

Funding Strength